Regencell Bioscience Holdings Limited
RGC
Rang in Aktien
#3298
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Aktienkurs
$10.61
Marktkapitalisierung
$5.26B
Veränderung (1 Tag)
-1.76%
Veränderung (1 Jahr)
-32.63%
Land
HK
Handel Regencell Bioscience Holdings Limited (RGC)
Kategorie
Healthcare
Kursverlauf für Regencell Bioscience Holdings Limited (RGC)
Höchster Schlusskurs: $8.39 am 2026-10-01
Niedrigster Schlusskurs: $0.24 am 2021-07-01
Niedrigster Schlusskurs: $0.24 am 2021-07-01
Kursverlauf der Aktie von Regencell Bioscience Holdings Limited von 2021 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -1.77% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $164.86 | 23.29% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $226.75 | 32.41% |
CH
|
|
| $18.43 | -4.03% |
IN
|
